{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:47:49Z","timestamp":1791042469707,"version":"4.1.0"},"reference-count":28,"publisher":"The Endocrine Society","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2000,9,1]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Mutations in LMNA, which encodes lamins A and C, have been found in patients with autosomal dominant Dunnigan-type familial partial lipodystrophy (FPLD). We analyzed the relationship between plasma leptin and the rare LMNA R482Q mutation in 23 adult FPLD subjects compared with 25 adult family controls with normal LMNA in an extended Canadian FPLD kindred. We found that the LMNA Q482\/R482 genotype was a significant determinant of plasma leptin, the ratio of plasma leptin to body mass index (BMI), plasma insulin, and plasma C peptide (P = 0.015, P = 0.0007, P = 0.0004, and P &amp;lt; 0.0001, respectively), but not BMI (P = 0.67). Family members who were heterozygous for LMNA Q482\/R482 had significantly lower plasma leptin and leptin:BMI ratio than unaffected R482\/R482 homozygotes. Fasting plasma concentrations of insulin and C peptide were both significantly higher in LMNA Q482\/R482 heterozygotes than in R482\/R482 homozygotes. Multivariate regression analysis revealed that the LMNA R482Q genotype accounted for 40.9%, 48.2%, 86.9%, and 81.0%, respectively, of the attributable variation in log leptin, leptin:BMI ratio, log insulin, and log C peptide (P = 0.013, P= 0.0007, P = 0.0002 and P &amp;lt; 0.0001, respectively). The results indicate that a rare FPLD mutation in LMNA determines the plasma leptin concentration. It remains to be established whether the reduction in leptin results from the reduced adipose tissue mass in FPLD or from another subcellular effect of mutant LMNA. It also remains to be established whether the insulin resistance in FPLD is a consequence of the reduced plasma leptin or of another functional change resulting from mutant LMNA.<\/jats:p>","DOI":"10.1210\/jcem.85.9.6768","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:06:07Z","timestamp":1389200767000},"page":"3089-3093","source":"Crossref","is-referenced-by-count":8,"title":["LMNA R482Q Mutation in Partial Lipodystrophy Associated with Reduced Plasma Leptin Concentration*"],"prefix":"10.1210","volume":"85","author":[{"given":"Robert A.","family":"Hegele","sequence":"first","affiliation":[{"name":"John P. Robarts Research Institute, London, Ontario, Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henian","family":"Cao","sequence":"additional","affiliation":[{"name":"John P. Robarts Research Institute, London, Ontario, Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray W.","family":"Huff","sequence":"additional","affiliation":[{"name":"John P. Robarts Research Institute, London, Ontario, Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol M.","family":"Anderson","sequence":"additional","affiliation":[{"name":"John P. Robarts Research Institute, London, Ontario, Canada N6A 5K8"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071614083705300_R1","first-page":"120","volume":"23","author":"Kobberling","year":"1986"},{"key":"2020071614083705300_R2","first-page":"128","volume":"23","author":"Burn","year":"1986"},{"key":"2020071614083705300_R3","first-page":"170","volume":"84","author":"Garg","year":"1999"},{"key":"2020071614083705300_R4","first-page":"109","volume":"9","author":"Cao","year":"2000"},{"key":"2020071614083705300_R5","first-page":"16321","volume":"268","author":"Lin","year":"1993"},{"key":"2020071614083705300_R6","first-page":"285","volume":"21","author":"Bonne","year":"1999"},{"key":"2020071614083705300_R7","first-page":"1715","volume":"341","author":"Fatkin","year":"1999"},{"key":"2020071614083705300_R8","first-page":"292","volume":"18","author":"Peters","year":"1998"},{"key":"2020071614083705300_R9","first-page":"804","volume":"85","author":"Hileman","year":"2000"},{"key":"2020071614083705300_R10","first-page":"953","volume":"1","author":"Lonnqvist","year":"1995"},{"key":"2020071614083705300_R11","first-page":"292","volume":"334","author":"Considine","year":"1996"},{"key":"2020071614083705300_R12","first-page":"503","volume":"83","author":"Pardini","year":"1998"},{"key":"2020071614083705300_R13","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.0.1400107","article-title":"Extremely low values of serum leptin in children with congenital generalized lipoatrophy.","volume":"140","author":"Jaquet","year":"1999","journal-title":"Eur J Endocrinol"},{"key":"2020071614083705300_R14","first-page":"435","volume":"7","author":"Meirhaeghe","year":"1998"},{"key":"2020071614083705300_R15","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1161\/01.ATV.18.8.1212","article-title":"Elevated low density lipoprotein triglyceride concentrations in subjects heterozygous for hepatic lipase S267F variant.","volume":"18","author":"Hegele,","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2020071614083705300_R16","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1016\/S0022-2275(20)34890-2","article-title":"Monogenic disorders of obesity and body fat distribution.","volume":"40","author":"Chen","year":"1999","journal-title":"J Lipid Res"},{"key":"2020071614083705300_R17","first-page":"796","article-title":"Plasma concentrations of leptin in children with lipodystrophy.","volume":"38","author":"Huzelbos","year":"1998","journal-title":"Int J Dermatol"},{"key":"2020071614083705300_R18","doi-asserted-by":"crossref","first-page":"27758","DOI":"10.1074\/jbc.272.44.27758","article-title":"Short term effects of leptin on hepatic gluconeogenesis and in vivo insulin action.","volume":"272","author":"Rossetti","year":"1997","journal-title":"J Biol Chem"},{"key":"2020071614083705300_R19","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1038\/38717","article-title":"Acute stimulation of glucose metabolism in mice by leptin treatment.","volume":"389","author":"Kamohara","year":"1997","journal-title":"Nature"},{"key":"2020071614083705300_R20","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1172\/JCI2849","article-title":"Obesity and diabetes in TNF-\u03b1 receptor-deficient mice.","volume":"102","author":"Schreyer","year":"1998","journal-title":"J Clin Invest"},{"key":"2020071614083705300_R21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1172\/JCI7901","article-title":"Surgical implantation of adipose tissue reverses diabetes in lipoatrophic mice.","volume":"105","author":"Gavrilova","year":"2000","journal-title":"J Clin Invest"},{"key":"2020071614083705300_R22","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1073\/pnas.96.5.2327","article-title":"Regulation of fatty acid homeostasis in cells: novel role of leptin.","volume":"96","author":"Unger","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"2020071614083705300_R23","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/(SICI)1099-0895(199812)14:4<263::AID-DMR233>3.0.CO;2-C","article-title":"Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years.","volume":"14","year":"1998","journal-title":"Diabetes Metab Rev"},{"key":"2020071614083705300_R24","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/S0002-9149(99)00350-1","article-title":"Cellular mechanisms of insulin resistance in humans.","volume":"84","year":"1999","journal-title":"Am J Cardiol"},{"key":"2020071614083705300_R25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/43448","article-title":"Leptin reverses insulin resistance and diabetes mellitus in mice with congenital lipodystrophy.","volume":"401","author":"Shimomura","year":"1999","journal-title":"Nature"},{"key":"2020071614083705300_R26","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1038\/72807","article-title":"LMNA, encoding lamin A\/C, is mutated in partial lipodystrophy.","volume":"24","author":"Shackleton","year":"2000","journal-title":"Nat Genet"},{"key":"2020071614083705300_R27","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/72221","article-title":"The envelope, please: nuclear lamins and disease.","volume":"6","year":"2000","journal-title":"Nat Med"},{"key":"2020071614083705300_R28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/72734","article-title":"Pushing the envelope on lipodystrophy.","volume":"24","year":"2000","journal-title":"Nat Genet"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/9\/3089\/9059061\/jcem3089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/85\/9\/3089\/9059061\/jcem3089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,22]],"date-time":"2022-03-22T00:05:30Z","timestamp":1647907530000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/85\/9\/3089\/2660485"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2000,9,1]]},"references-count":28,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2000,9,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.85.9.6768","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[2000,9,1]]}}}